Healthcare analytics platform Arcadia has joined the Atropos Evidence Network, for informed decision-making in value-based care.   

This integrates Atropos’ evidence generation capabilities into Arcadia’s data platform. 

Through this alliance, Arcadia’s provider clients gain entry to Atropos Health’s suite of evidence-generating applications, supporting comprehensive patient care and optimising performance in value-based models.  

Subscribers to Atropos Health from within the Arcadia network can expedite tailored clinical decision-making, aiming to provide care based on individual patient physiology.  

Atropos Health CEO and co-founder Dr Brigham Hyde said: “This optimisation is what Atropos Health delivers across our products, and we’re proud to bring the high-quality data Arcadia is known for into the Atropos Evidence Network.  

“This collaboration further enables healthcare providers to generate novel peer-reviewed evidence rapidly to make data-driven decisions on optimal clinical guidelines, care pathways, and the best interventions to succeed in value-based care and other quality initiatives.” 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Additionally, Atropos Health’s Life Sciences users can conduct real-world evidence studies by leveraging Arcadia’s longitudinal research dataset within the Atropos Evidence Network. 

This announcement follows Atropos Health’s recent launch of Geneva OS and ChatRWD applications, incorporating generative AI capabilities for evidence generation.  

Atropos Health has also formed a Life Sciences Advisory Board, including executives from prominent pharmaceutical companies.  

Customers can use Atropos Health’s evidence-generation tools through the federated installation of Geneva OS, accessing services such as the Green Button Informatics Consult Service and the CRAFT Emulation Toolkit for trial design improvement and real-world data analysis. 

Arcadia president and CEO Michael Meucci said: “Arcadia’s collaboration with Atropos Health empowers care organisations to provide high-quality, cost-effective care that helps improve patient outcomes through democratised access to clinical research evidence. 

“Integrating Atropos Health’s generative AI capability into Arcadia’s data platform is the latest example of how we’re equipping our customers with plug-and-play access to proprietary and third-party enablers that improve workflows and support value-based performance goals.”